1-215628969-A-G
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBS2_Supporting
The ENST00000307340.8(USH2A):āc.15364T>Cā(p.Cys5122Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000532 in 1,613,996 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
ENST00000307340.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USH2A | NM_206933.4 | c.15364T>C | p.Cys5122Arg | missense_variant | 71/72 | ENST00000307340.8 | NP_996816.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USH2A | ENST00000307340.8 | c.15364T>C | p.Cys5122Arg | missense_variant | 71/72 | 1 | NM_206933.4 | ENSP00000305941 | P1 | |
USH2A | ENST00000674083.1 | c.15436T>C | p.Cys5146Arg | missense_variant | 72/73 | ENSP00000501296 |
Frequencies
GnomAD3 genomes AF: 0.000296 AC: 45AN: 152130Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000251 AC: 63AN: 251440Hom.: 0 AF XY: 0.000243 AC XY: 33AN XY: 135894
GnomAD4 exome AF: 0.000556 AC: 813AN: 1461748Hom.: 2 Cov.: 32 AF XY: 0.000496 AC XY: 361AN XY: 727174
GnomAD4 genome AF: 0.000296 AC: 45AN: 152248Hom.: 0 Cov.: 32 AF XY: 0.000296 AC XY: 22AN XY: 74450
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 30, 2022 | The p.Cys5122Arg variant in USH2A has been reported in one individual with hearing loss who also harbored a truncating variant in USH2A, though it was not clear whether these variants were confirmed in trans (Bonnet 2016). It has also been reported in two individuals who were found to have alternate explanations of their hearing loss or retinal dystrophy (Glockle 2013, LMM unpublished data). This variant has also been identified in 3 additional individuals with hearing loss by our laboratory; however, none of the individuals harbored a second variant on the remaining copy of USH2A. This variant has been identified in 0.047% (60/126682) of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs111033402); however, its frequency is not high enough to rule out a pathogenic role. The cysteine (Cys) residue at position 5122 is not conserved in mammals or evolutionary distant species. Additional computational prediction tools do not provide strong support for or against an impact to the protein.In summary, while its frequency suggests it is more likley to be benign, the clinical significance of this variant is uncertain. ACMG/AMP Criteria applied: None. - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jun 05, 2023 | In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Identified in a patient with Usher syndrome in the published literature who also harbored another USH2A variant, although parental studies were not performed to determine the phase of these two variants (Bonnet et al., 2016); This variant is associated with the following publications: (PMID: 32141364, 23591405, 34426522, 27460420) - |
Usher syndrome type 2A Uncertain:2
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Feb 13, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Myriad Genetics, Inc. | Oct 27, 2021 | NM_206933.2(USH2A):c.15364T>C(C5122R) is a missense variant classified as a variant of uncertain significance in the context of USH2A-related disorders. C5122R has been observed in cases with relevant disease (PMID: 27460420, 23591405). Functional studies of this variant are not available in the literature. C5122R has been observed in population frequency databases (gnomAD NFE 0.05%). In summary, there is insufficient evidence to classify NM_206933.2(USH2A):c.15364T>C(C5122R) as pathogenic or benign. Please note: this variant was assessed in the context of healthy population screening. - |
Usher syndrome type 2A;C3151138:Retinitis pigmentosa 39 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 12, 2022 | - - |
Retinal dystrophy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg | Jan 01, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at